-
Assessment of the corpus callosum at 20-24 weeks' gestation by three-dimensional ultrasound examination.
Plasencia W, Dagklis T, Borenstein M, Csapo B, Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:169-72. -
Nuchal translucency and the risk of congenital heart disease.
Hyett J, Sonek J, Nicolaides KH.
Obstet Gynecol 2007;109:1455-6. -
Predictors of neonatal outcome in early-onset placental dysfunction.
Baschat AA, Cosmi E, Bilardo CM, Wolf H, Berg C, Rigano S, Germer U, Moyano D, Turan S, Hartung J, Bhide A, Muller T, Bower S, Nicolaides KH, Thilaganathan B, Gembruch U, Ferrazzi E, Hecher K, Galan HL, Harman CR.
Obstet Gynecol 2007;109:253-61. -
Maternal cardiac function in fetal growth-restricted and non-growth-restricted small-for-gestational age pregnancies.
Bamfo JE, Kametas NA, Chambers JB, Nicolaides KH.
Ultrasound Obstet Gynecol 2007;29:51-57. -
Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions.
Scheier M, Hernandez-Andrade E, Fonseca EB, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1550-6. -
Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction.
Savvidou MD, Yu CK, Harland LC, Hingorani AD, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1668-73. -
Fetal growth restriction and postnatal development.
Eleftheriades M, Creatsas G, Nicolaides K.
Ann N Y Acad Sci 2006;1092:319-30. -
Maternal cardiac function in fetal growth restriction.
Bamfo JE, Kametas NA, Turan O, Khaw A, Nicolaides KH.
BJOG 2006;113:784-91. -
Nuchal translucency as a marker of congenital heart disease.
Perdu M, Hyett JA, Sharland G, Snijders RS, Nicolaides KH.
Contracept Fertil Sex 1999;27:I-V. -
Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks.
Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;14:307-10. -
Assessment of umbilical arterial and venous flow using color Doppler.
Lees C, Albaiges G, Deane C, Parra M, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;14:250-5. -
Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.
Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH.
BMJ 1999;318:81-5.